Tech Company Financing Transactions
NuView Life Sciences Funding Round
NuView Life Sciences secured a $90 million funding round on 8/4/2020. Backers included Global Emerging Markets.
Transaction Overview
Company Name
Announced On
8/4/2020
Transaction Type
Venture Equity
Amount
$90,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to complete a 600-patient in vitro double-blind clinical trial in accordance with the U.S. Food and Drug Administration (FDA) approval process.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1389 Center Dr. 200
Park City, UT 84098
USA
Park City, UT 84098
USA
Phone
Website
Email Address
Overview
NuView Life Sciences is an inventive, precision oncology company working to change the way cancer is currently diagnosed and treated. This positioning is dependent on attention to NuView Life Sciences's platform technology, NV-VPAC1, and its action in the body.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Crowe
Chief Financial Officer
Thomas Brown
Chief Scientific Officer
Robert Wassman
VP - Bus. Development
Steven Penderghast
Browse more venture capital transactions:
Prev: 8/4/2020: Volante Technologies venture capital transaction
Next: 8/4/2020: Palmetto venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs